에 대한 최신 뉴스 Impact BioMedical (AMEX:IBO) 주식

Impact BioMedical

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Impact BioMedical Inc

International Bancshares Corporation - Common Stock

International Bancshares Corp

UNIVERSAL IBOGAINE INC by Universal Ibogaine Inc.

Universal Ibogaine Inc

INDUSTRIAL BK KOREA S/GDR by Industrial Bank of Korea

Industrial Bank of Korea

VanEck Robotics ETF

News

Legal

Press Releases

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

IPOs

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

Positioned for Growth: Impact BioMedical Inc.'s (NYSEAmerican: IBO) Push into Cancer and Immune Health

Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthroughs

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Impact BioMedical Inc. to Present at The Microcap Conference

Health Care

Impact Biomedical Inc. Announces Acquisition of Celios®, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"

Contracts

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Impact Biomedical Inc. Announcement Stock Activity/Pricing

PRPH

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

CalciMedica

Cara Therapeutics

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Dare Bioscience

Durect

Grace Therapeutics

Hoth Therapeutics

IGC Pharma

Opus Genetics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

ProPhase Labs

Pulmatrix

Talphera

Traws Pharma

VYNE Therapeutics

Comments

Impact BioMedical

뉴스

에 대한 최신 뉴스 Impact BioMedical (AMEX:IBO) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌